EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment. Chen Q, Xia L, Wang J, Zhu S, et al. Lung Cancer 2024;192:107815.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen Q, Xia L, Wang J, Zhu S, et al. EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment. Lung Cancer 2024;192:107815.
PMID: 38754276